Peak6 Investments LLC Novavax Inc Put Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $89,856 - $194,688	15,600 Added 62.15%	40,700 $282,000
Q4 2022 Feb 10, 2023	SELL	$8.86 - $25.04 $1.62 Million - $4.56 Million	-182,300 Reduced 87.9%	25,100 $258,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.49 Million - $6.24 Million	82,000 Added 65.39%	207,400 $3.78 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $1.25 Million - $2.59 Million	-34,400 Reduced 21.53%	125,400 $6.45 Million
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $17.1 Million - $35.1 Million	-245,800 Reduced 60.6%	159,800 $11.8 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $29.1 Million - $47.1 Million	216,100 Added 114.04%	405,600 $58 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $25 Million - $38.1 Million	-140,700 Reduced 42.61%	189,500 $39.3 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $40 Million - $85.1 Million	330,200 New	330,200 $70.1 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.